About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Best’s Market Segment Report: US Health Insurers Met Challenges in 2024 but Pressures Expected to Persist in 2025

Operating performance for the U.S. health insurance industry remained favorable through third-quarter 2024 with net income of $31 billion, although underwriting results have been pressured by Medicare Advantage (MA) and Medicaid managed care earnings declines, amid increased cost of care including pharmaceutical cost spend.

The annual Review & Preview Best's Market Segment Report, “US Health Insurers Met Challenges in 2024, but Pressures Expected to Persist in 2025,” notes that the commercial segment reported a year-over-year underwriting gain of 75% in 2023, driven by premium revenue growth from the individual segment. Cost trends in the commercial segment have been above historical levels, but the industry priced for this leading into 2025. Therefore, AM Best expects operating trends for the commercial segment to remain profitable through year-end 2024 and again in 2025.

“For the past several years, the industry balanced lower earnings in the commercial segment with steady and increasing profitability in the government program segments, but this trend has reversed as earnings in MA and Medicaid managed care have been challenged while the commercial segment’s premium trend continues to offset the narrowing margins of the several years prior,” said Joseph Zazzera, director, AM Best.

Through third-quarter 2024, the health segment’s overall underwriting gain of $17.5 billion represented a 65% decrease from the same prior-year period. According to the report, several headwinds have led to a drop in underwriting gains in the MA segment, including 2024 pricing that did not appropriately factor in an uptick in medical costs in 2023 and high levels of utilization, along with regulatory factors (e.g., Star ratings, risk adjustment payments and overall reimbursement rates) that likely will negatively affect MA margins into 2025.

In the Medicaid segment, although companies were prepared for an enrollment decline once redeterminations resumed in 2023, the majority of disenrolled members tended to be healthier members, resulting in higher acuity of the remaining member population in the segment. Necessary rate increases also have also lagged the acuity levels, which has led to margin compression pressures in the segment.

“Medicaid is a more capital-intensive product, which has higher charges when calculating risk-adjusted capital. However, this has been somewhat offset by continued growth in individual Affordable Care Act products and MA,” said Sally Rosen, senior director, AM Best.

Pharmacy costs continue to rise, driven by higher-cost pharmaceuticals, including biosimilars and gene therapies. The rapid increase in the number of individuals taking glucagon-like peptide-1 (GLP-1) drugs has also contributed to escalating costs. In 2024, the rate of increase in pharmacy claims was in the double digits and accounted for over 13% of total medical claims. In addition to GLP-1 drugs, gene and cell therapies, as well as high-cost injectable drugs, have contributed to the rising overall cost trend. Insurers have tried to manage these costs by directing patients’ sites of care to lower cost options, such as at-home administration, but the growing pipeline of drugs for 2025 will likely make pharmaceuticals an ongoing concern.

AM Best expects the U.S. health industry to remain profitable for year-end 2024 and should see similar earnings trends in 2025, with a decline in overall underwriting income due to lower results for MA and Medicaid managed care. However, the commercial segment’s earnings should remain favorable. Premium generation will still be supported by business expansion, the ongoing aging-in of seniors into MA and rate increase actions across the various product lines.

To access the full copy of this Review & Preview report, which includes sections on publicly traded health insurers, Blue Cross and Blue Shield plans and other segments such as dental and disability, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=351661.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.